- Published on: March 15, 2022
- 18:12
Washington, March 15 (Prensa Latina) A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to the chemotherapy agent cisplatin in head and neck cancers and restores tumor-killing effects of cisplatin in animal models.
